Kmart Corporation Agrees to Pay $32.3M to Settle Drug Fraud Allegations
A $32.3 million settlement has been reached between Kmart Corporation and the United States government, bringing an end to allegations that “in-store pharmacies in Kmart stores failed to report discounted prescription drug prices to Medicare Part D, Medicaid, and TRICARE, the health program for uniformed service members and their families.” The lawsuit itself was filed against Kmart Corporation, a “wholly owned subsidiary of Sears Holdings Corporation (SHC),” back in 2008.
